ArticleJournal of Cancer2024

DHX34 as a promising biomarker for prognosis, immunotherapy and chemotherapy in Pan-Cancer: A Comprehensive Analysis and Experimental Validation.

Nanbin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.